Background: Nanomaterials that exhibit intrinsic enzyme-like characteristics have shown great promise as potential antibacterial agents. However, many of them exhibit inefficient antibacterial activity and biosafety problems that limit their usefulness. The development of new nanomaterials with good biocompatibility and rapid bactericidal effects is therefore highly desirable. Here, we show a new type of terbium oxide nanoparticles (Tb 4 O 7 NPs) with intrinsic oxidase-like activity for in vitro and in vivo antibacterial application.
Background
Wound infection is an important cause of poor wound healing and its treatment often requires the use of antibiotics [1, 2] . However, excessive use of antibiotics may lead to the development of antibiotic-resistant bacteria, and may also cause side effects on human health, such as gastrointestinal disturbances. In recent years, developments in nanomaterial technology have provided an opportunity to develop novel antimicrobial agents. Due to the diversity in mechanisms of action against bacteria, bacterial cells are less likely to develop antibacterial resistance compared to existing antibiotics [3] [4] [5] . However, most of these nanomaterials have application limitations, such as cytotoxicity, not biocompatible for human use, and environmental concerns.
Nanozymes are nanomaterials that catalyze the same reactions originally catalyzed by natural enzymes in biological systems [6] [7] [8] . Over the past several years, a wide variety of nanomaterials, such as noble metals [9] [10] [11] , metal oxides [12] [13] [14] , and carbon nanomaterials [15] [16] [17] [18] , have been explored as potential nanozymes. Based on their intrinsic enzyme-like activity, several nanozymes have been used in antibacterial applications [19] [20] [21] [22] [23] . For instance, platinum nanomaterials have shown effective antibacterial activity in the presence of hydrogen peroxide (H 2 O 2 ) [24] . The antibacterial activity of these nanozymes are attributed primarily to their oxidase-and peroxidase-like activities that catalyze the production of hydroxyl radicals (·OH) in the presence of exogenous H 2 O 2 and enhance the cellular levels of reactive oxygen species (ROS) within bacteria cells. Fang et al. also showed that palladium nanomaterials with oxidase-and peroxidase-like activities displayed effective antibacterial activity in the presence of H 2 O 2 [25] . Although many reported enzyme-like nanomaterials have been proposed as novel antibacterial agents, the high price and persistence in living tissues are still important issues. Moreover, the application of H 2 O 2 in human wound disinfection is harmful to healthy tissue and may delay wound healing [26] .
Terbium oxide nanoparticles (Tb 4 O 7 NPs) have been extensively used as precursors for the synthesis of lanthanide nanophosphors and superconductor materials [27, 28] . For example, Tb 4 O 7 complexed with reduced graphene oxide composite exhibit typical green emission of terbium ions as well as the blue self-luminescence of graphene [28] . In addition, it has been found that Tb 4 O 7 NPs can be used as analytical reagents for food analysis [29] . Compared with noble metal nanomaterials, Tb 4 O 7 NPs are easier to synthesize and are less expensive. However, a review of scientific literature was unable to find any studies that described the enzyme-like activity of Tb 4 
Materials and methods

Chemicals and materials
Characterization of Tb 4 O 7 NPs
The hydrodynamic size and zeta potential of the Tb 4 O 7 NPs were measured using a Zetasizer Nano-ZS (Malvern, UK). The morphology and size of the Tb 4 O 7 NPs were characterized using a transmission electron microscopy (TEM, Tecnai G-20, FEI). The UV-vis absorption spectrum was recorded on a spectrophotometer (UV-3600, Shimadzu).
Electron spin resonance spectroscopic measurements
The electron spin resonance (ESR) measurements were carried out using a Bruker EMX ESR spectrometer according to our previous study [3, 9] . The final concentration of each component is described in each figure caption. All the ESR measurements were carried out at ambient temperature.
Measurement of intracellular ROS
After Tb 4 O 7 NPs (100 μg/mL) treatment, bacteria (1 × 10 9 CFU/mL) were collected by centrifugation and incubated with DCFH-DA (10 µM) for 30 min at dark, and stained bacteria were visualized with a confocal laser microscopy.
Cytotoxicity experiments
HUVECs were employed for investigating the cytotoxicity of Tb 4 O 7 NPs. HUVECs were seeded at a density of 1 × 10 5 cells/well in 96-well plates and incubated overnight. The HUVECs were then incubated with Tb 4 O 7 NPs (0-100 μg/mL) for 24 h, and cell viability was measured by MTT assay.
Mice injury model
BALB/c mice (8 weeks) were purchased from Pengsheng. On the day 0, the mice were anesthetized using 10% chloral hydrate. Then, the dorsal hair of mouse was shaved, full-thickness skin wounds with the diameter of 10 mm were created on the back of each mouse. After 24 h (day 1), the mice were treated with 50 μL PBS or Tb 4 O 7 NPs (100 μg/mL). The Tb 4 O 7 NPs were dripping on the surface of the wound.
Hemolysis test
Fresh blood was collected under sterile conditions from healthy BALB/c mice (n = 5) into an anticoagulation tube. The red blood cells were precipitated by centrifugation at 2000 rpm for 10 min and washed three times with PBS buffer solution to obtain red blood cells. The appropriate amount of red blood cells was diluted five times with PBS buffer solution to prepare a red blood cell solution. 20 μL of the diluted red blood cell suspension was mixed with a series of different concentrations of Tb 4 O 7 NPs (0-200 μg/mL); ultrapure water was used as control. All the above samples were incubated at 37 °C for 2 h, centrifuged at 2000 rpm for 10 min, imaged, and the supernatant after centrifugation was taken in a 96-well plate to measure the absorbance at 540 nm using a microplate reader. The hemolysis rate was calculated as follows:
Results and discussion
Characterization of Tb 4 O 7 NPs
The Tb 4 O 7 NPs used in the present study were purchased from US Research Nanomaterials, Inc. The physical characterization of Tb 4 O 7 NPs is shown in Additional file 1: Figure S1 and included images of particle core size and shape captured by TEM, the mean and homogeneity of Hemolysis rate (%) = sample absorption − negative control absorption / positive control absorption − negative control absorption × 100%, and hemolysis rate exceeding 5% is considered hemolysis.
particle hydrodynamic size by dynamic light scattering (DLS), and particle absorption spectrum by UV-vis. According to TEM and DLS data, the dispersity of Tb 4 O 7 NPs is poor. The mean core particle size of Tb 4 O 7 NPs is approximately 200 nm (Additional file 1: Figure S1a,  b) ; while the DLS result of Tb 4 O 7 NPs is around 400 nm (Additional file 1: Figure S1c ). This is mainly due to the size measured by DLS was a hydrodynamic size, and therefore the nanoparticles showed a larger hydrodynamic volume due to solvent effect in the hydrated state. The zeta potential value of Tb 4 O 7 NPs is 31.6 mV in water. The UV-vis spectrum of Tb 4 O 7 NPs is shown in Additional file 1: Figure S1d .
Catalytic activity of Tb 4 O 7 NPs as oxidase mimetics
The oxidase-like activity of Tb 4 O 7 NPs was evaluated using the substrate TMB. The UV-vis spectroscopy measurements show time-dependent increases in TMB oxidation catalyzed by Tb 4 O 7 NPs, yielding a bluecolored product (Fig. 1a, b ). In addition, Tb 4 O 7 NPs can also catalyze the oxidation of ABTS and OPD (Fig. 1a) .
We used the oxidation of TMB as a model reaction and found that the catalytic efficiency of the Tb 4 O 7 NPs is dependent on TMB concentrations, pH and temperature ( Fig. 1c and Additional file 1: Figure S2 ). As shown Figure S2b ). We adopted pH 3.6 and 25 °C (room temperature) as the standard conditions for subsequent studies.
Next, we determined the apparent steady-state kinetic parameters for the reaction of Tb 4 O 7 NPs with TMB. Typical Michaelis-Menten curves were established (Fig. 1d) . The curves were then fitted to the double-reciprocal Lineweaver-Burk plots (Fig. 1e) , from which the kinetic parameters shown in Table 1 were determined. NPs was increased to 100 μg/mL, nearly 90% of the S. aureus were killed. A similar trend of antibacterial effects were observed towards the E. coli.
Effects of Tb
To further investigate the interaction between Tb 4 O 7 NPs and bacteria, a fluorescent-based cell live/dead assay was conducted. As shown in Fig. 3c, d , Tb 4 O 7 NPs exhibited significant antibacterial activity against both S. aureus and E. coli, which was consistent with the aforementioned results. The exposure of S. aureus cells to Tb 4 O 7 NPs at a concentration of 100 μg/mL resulted in nearly 100% lethality, as evidenced by the dominant red fluorescent signal. At a concentration of 50 μg/mL, Tb 4 O 7 NPs completely inhibited the bacterial growth of E. coli.
The morphology and membrane integrity of bacteria were then determined by SEM (Fig. 3c, d) . Untreated S. aureus displayed a typical rod-shaped structure with a continuous, smooth surface. When exposure to the 50 μg/mL of Tb 4 O 7 NPs, the S. aureus bacterial cell walls became partially wrinkled and discontinuance. Notably, after treatment with 100 μg/mL of Tb 4 O 7 NPs, the S. aureus bacterial cell walls showed much more pronounced damage, indicating stronger antibacterial effects at higher concentrations of Tb 4 O 7 NPs. A similar tendency was found for E. coli. The loss of membrane integrity of E. coli was observed at concentrations lower than 100 μg/mL of Tb 4 O 7 NPs treatment. Moreover, Tb 4 O 7 NPs were observed by SEM and SEM-energy dispersive X-ray spectroscopy (EDS) to aggregate on the surfaces of S. aureus and E. coli (Additional file 1: Figure S4 ).
It is known that the proton motive force decreases the local pH (as low as pH 3.0) in the cytoplasm and membrane of bacteria cells [33, 34] . Since we found that Tb 4 O 7 NPs exhibit oxidase-like activity under acidic conditions, we speculate that the antibacterial mechanism of Tb 4 O 7 NPs may arise from their oxidase activity to accelerate the process of bacterial cell oxidation and consumption of antioxidant biomolecules, leading to a reduction of oxygen products including H 2 O 2 along with other antibacterial activity from the accumulation of ROS. To confirm this hypothesis, the intracellular levels of ROS were determined using the florescent probe, DCFH-DA (Fig. 4) . For both S. aureus and E. coli, the untreated cells showed extremely weak fluorescence, indicating low levels in the formation of intracellular ROS. In contrast, bacterial cells exposed to Tb 4 O 7 NPs showed high levels of ROS formed within the cellular cytoplasm, as evidenced by the strong fluorescence signal. We also found that the generation of ROS is Tb 4 O 7 NPs dose-dependent (Additional file 1: Figure S5 ).
In vivo wound disinfection effect of Tb 4 O 7 NPs
The above findings suggest that Tb 4 O 7 NPs may have role as an antibacterial agent for bacterial infections in vivo. To assess the antibacterial capacity of Tb 4 O 7 NPs in vivo, a wound infection model was constructed using BALB/c mice. A wound was introduced on the back of the mouse and an infection was established by implanting S. aureus into the wounded area. After infection was established, PBS or Tb 4 O 7 NPs were applied to the infected wound. Figure 5a , b shows the progress of the wounds. Compared with the control (PBS treatment) group after 3 days, the wound area was reduced under Tb 4 O 7 NPs treatment. After treating of 7 days with Tb 4 O 7 NPs treatment, the wounds were nearly healed completely. In contrast, obvious scab was observed from the control group, indicating incomplete recovery.
Biosafety of Tb 4 O 7 NPs
Biosafety is an important factor for antimicrobial agents designers. To assess the biosafety of Tb 4 O 7 NPs, we first determined the effects of Tb 4 O 7 NPs on red blood cells and HUVECs in vitro. The effect of Tb 4 O 7 NPs on cell membrane disrupt was first determined by a red blood cell hemolysis assay. As shown in Fig. 6a , pure water can cause severe red blood cells hemolysis within 2 h. In contrast, the introduction of Tb 4 O 7 NPs did not cause signs of hemolysis. In this experimental result, the hemolysis rate was still less than 1% at a concentration of 100 µg/ mL, which fully demonstrated that Tb 4 O 7 NPs have good blood compatibility. Meanwhile, the cytotoxicity tests on mammalian cells HUVECs further confirm the biosafety of Tb 4 O 7 NPs (Fig. 6b) .
Then, the biosafety of Tb 4 O 7 NPs in vivo were determined. As shown in Fig. 7a , the indicators in blood were within the normal range. The major mouse organs (heart, liver, spleen, lung, and kidney) were formalin-fixed and processed for the evaluation of H&E sections by (Fig. 7b) . No obvious mouse organ damage was observed from Tb 4 O 7 NPs treatment.
Conclusions
In summary, this study demonstrates for the first time that Tb 4 O 7 NPs exhibit oxidase-like activity. In addition, the results of this study established a relationship between the oxidase-like enzyme activity of Tb 4 O 7 NPs and their antibacterial properties. The data collected from this work revealed that the oxidase-like activity of Tb 4 O 7 NPs was able to function with a variety of substrates, including biomolecules, and resulted in the generation of ROS, which further enhanced their antibacterial activity. The application of the antibacterial activities of Tb 4 O 7 NPs were demonstrated in a wound infection mouse model. Our study provides evidence that Tb 4 O 7 NPs can be utilized as an efficient antibacterial agent and the potential applications in wound healing are promising. 
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